Efficacy of a Unani formulation in Dyslipidaemia
Phase 2
- Conditions
- Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
- Registration Number
- CTRI/2023/10/059299
- Lead Sponsor
- ational Research Institute of Unani Medicine For Skin Disorders
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Newly diagnosed participants of any sex aged 30-60 years.
Participants having any one or more of following lipid abnormality in blood:
Serum Cholesterol equal to or more than 200mg/dl.
HDL-C less than 40 mg/dl.
LDL Cholesterol equal to or more than 130 mg/dl.
Serum Triglycerides level equal to or more than 150mg/dl and/or less than 400 mg/dl.
Body Mass Index (BMI) 23-40 kg/m2.
Exclusion Criteria
Participants having hypothyroidism, diabetes mellitus, history and clinical evidence of angina, myocardial infarction (MI).
Pregnant or Lactating Women.
Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction.
Known cases of Immunocompromised states (HIV/ AIDS, etc)/ Malignancies.
Participants not willing to attend treatment schedule regularly.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method